Accolade Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	0.2	0.19	0
Operating Expenses	-0.6	0.19	0
Operating Income	0.6	-0.19	-0
Interest Expense	-0.02	-0.01	-0
Currency Exchange Gain (Loss)	-0.01	0	-0
Other Non Operating Income (Expenses)	0	-0	-
EBT Excluding Unusual Items	0.57	-0.19	-0
Gain (Loss) on Sale of Investments	4.11	-1.15	-
Pretax Income	4.68	-1.34	-0
Income Tax Expense	1.36	-0.4	-
Net Income	3.32	-0.95	-0
Net Income to Common	3.32	-0.95	-0
Shares Outstanding (Basic)	4,077	4,077	-
Shares Outstanding (Diluted)	4,077	4,077	-
EPS (Basic)	0.00	-0.00	-
EPS (Diluted)	0.00	-0.00	-
EBIT	0.6	-0.19	-0

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.